SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer
Cited by 52
Related Papers
Sulconazole Induces PANoptosis by Triggering Oxidative Stress and Inhibiting Glycolysis to Increase Radiosensitivity in Esophageal Cancer
|Molecular & Cellular Proteomics|2023|74
Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma
|Nucleic Acids Research|2021|27
Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation
|Genome biology|2023|21
Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation
|Oncotarget|2015|15
TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis
|BioMed Research International|2022|15